JCL-23234-00623
3 vaccinations
3 coded responses
30 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 303 / GA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
-
2021-02-20
Survey response — day 21, dose 2MedDRA: Sinusitis — Feeling: FairFree text: Sinus infection IMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
-
2021-08-30
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — day 28, dose 3MedDRA: Irritable bowel syndrome, Pre-existing disease — Feeling: Fair · Be unable to work or attend schoolFree text: Irritable Bowel Syndrome flare up. Unrelated to covidMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-11
- 2021-11-29
-
2022-02-28
Survey response — 6 months, dose 3MedDRA: Irritable bowel syndrome, Migraine, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Migraines and IBS episodes increasedMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-08-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — day 21, dose 2
Symptoms: Sinus infection I
Release 9 — day 28, dose 3
Symptoms: Irritable Bowel Syndrome flare up. Unrelated to covid
Release 11 — 6 months, dose 3
Symptoms: Migraines and IBS episodes increased
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Irritable bowel syndrome | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release